Stefano Frausin

Dr. Stefano Frausin

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
CECharlotte Ermine
Charlotte Ermine
JNJess Nithianantharajah
Jess Nithianantharajah
KOKatrina O’brien
Katrina O’brien
JKJessica A. Kauhausen
Jessica A. Kauhausen
SFStefano Frausin
Stefano Frausin
LTLachlan H. Thompson
Lachlan H. Thompson

Verified
Journal Article
Open access
PDF file
BKBrett Kagan
Brett Kagan
CECharlotte Ermine
Charlotte Ermine
SFStefano Frausin
Stefano Frausin
CPClare L. Parish
Clare L. Parish
JNJess Nithianantharajah
Jess Nithianantharajah
LTLachlan H. Thompson
Lachlan H. Thompson
Neonatal arterial ischemic stroke is one of the more severe birth complications. The injury can result in extensive neurological damage and is robustly associated with later diagnoses of cerebral palsy (CP). An important part of efforts to develop new therapies include the on-going refinement and understanding of animal models that capture relevant clinical features of neonatal brain injury leading to CP. The potent vasoconstrictor peptide, Endothelin-1 (ET-1), has previously been utilised in animal models to reduce local blood flow to levels that mimic ischemic stroke. Our previous work in this area has shown that it is an effective and technically simple approach for modelling ischemic injury at very early neonatal ages, resulting in stable deficits in motor function. Here, we aimed to extend this model to also examine the impact on cognitive function. We show that focal delivery of ET-1 to the cortex of Sprague Dawley rats on postnatal day 0 (P0) resulted in impaired learning in a touchscreen-based test of visual discrimination and correlated with important clinical features of CP including damage to large white matter structures.

2 June 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
CPChiara Pavan
Chiara Pavan
KLKristian Honnens de Lichtenberg
Kristian Honnens de Lichtenberg
CGCarlos William Gantner
Carlos William Gantner
SFStefano Frausin
Stefano Frausin
JCJoseph Chen
Joseph Chen
CPClare L. Parish
Clare L. Parish
SUMMARY: The survival of transplanted ventral midbrain (vm) dopaminergic neurons (DAn) and their innervation of host striatal tissue are crucial for ameliorating motor symptoms in Parkinson’s disease (PD). However, human pluripotent stem cells (hPSC) show inferior axonal plasticity compared to fetal donor tissue. While modulation of the host environment with trophic cues, such as glial cell-derived neurotrophic factor (GDNF), can improve graft outcomes, these cues lack specificity for DAn, resulting in plasticity of other neurons within the graft. Using single nuclei RNA sequencing, we identified axonal guidance pathways (Semaphorin, Netrin and Wnt) that were preferentially activated in DAn within the graft. Overexpression of Semaphorin3A/SEMA3A, Netrin1/NTN1 or WNT5A in the striatum of Parkinsonian mice following vm DA progenitor transplantation promoted A9-DA specification and selectively increased DA innervation of the host striatum, without off-target extrastriatal DA innervation observed in response to GDNF. In Parkinsonian rats, NTN1 overexpression promoted graft-induced motor recovery, selective DA plasticity and activation of postsynaptic striatal neurons without evidence of non-DAn plasticity. Further, snRNA-sequencing of NTN1 or GDNF-treated grafts confirmed the upregulation of DA-specific plasticity by NTN1, while GDNF promoted plasticity in both DA and non-DAn. These findings highlight the capacity to improve on-target integration of hPSC-derived DAn in grafts by selectively targeting DA-specific plasticity. Taken together, these results demonstrate the utility of DA-specific cues to promote functional recovery, improve graft predictability, and limit off-target innervation.